1 / 37

Case-Control Studies

Case-Control Studies. Afshin Ostovar Bushehr University of Medical Sciences Bushehr, 2011. The sophisticated use and understanding of case-control studies is the most outstanding methodologic development of modern epidemiology . ( Rothman 1986, p. 62 )

tracie
Télécharger la présentation

Case-Control Studies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case-Control Studies Afshin Ostovar Bushehr University of Medical Sciences Bushehr, 2011

  2. The sophisticated use and understanding of case-control studies is the most outstanding methodologic development of modern epidemiology. (Rothman 1986, p. 62) • A primary goal is to reach the same conclusions in a retrospective study as would have been obtained from a forward study, if one had been done. (Mantel and Haenszel 1959, p. 722)

  3. Key advantages • Statistically efficient for rare conditions • Logistically efficient for prolonged induction or latency diseases • Can examine many exposures in one study • Ethical - cannot affect onset of disease

  4. Case-Control Studies • Examines the association between disease and potential risk factors by taking separate samples of diseased cases and of controls at risk of developing disease. • Information may be collected for both cases and controls on genetic, social, behavioral, environmental or other determinants of disease risk.

  5. Odds Ratio (cross-product ratio)

  6. The initial interpretation of the case-control study was the comparison of exposure histories for a group of diseased cases with those for non-diseased controls. • The critics argued that such comparisons provided no information about the quantities of true epidemiologic interest, namely the disease rates. • Cornfield (1951) corrected this misconception by demonstrating that the exposure odds ratio for cases vs. controls was equal to the disease odds ratio for exposed vs. non-exposed.

  7. Selection of cases and controls • Matching • Case-control studies based on a defined cohort

  8. Selection of cases • Sources for cases • Problems in case selection • Incident or Prevalent Cases

  9. Sources for cases • Hospitals • Physicians— practices, or clinics • Registries

  10. Problems in case selection • If cases are selected from a single hospital, any risk factors that are identified may be unique to that hospital as a result of referral patterns or other factors, and the results may not be generalizable to all patients with the disease. • Furthermore, if the hospital from which the cases are drawn is a tertiary care facility, which selectively admits severely ill patients, any risk factors identified in the study may be risk factors only in persons with severe forms of the disease.

  11. Incident or Prevalent Cases • Number of cases available • Survival bias

  12. Principles of Control Selection • The “study-base” Principle • The Deconfounding Principle • The Comparable Accuracy Principle

  13. The “study-base” Principle • Controls be randomly selected from disease-free members of the underlying cohort, also known as the source population or study-base at the times that cases are being ascertained • When controls are in fact selected later, it sometimes mandates the random selection of a reference date for each control so that the distributions of the case diagnosis dates and control reference dates are comparable.

  14. The “study-base” Principle. Cont. • Only exposures occurring prior to the reference|diagnosis date would be taken into account. • This principle also implies that whatever exclusion criteria have been applied to the cases must also be applied equally to the controls.

  15. The Deconfounding Principle • This principle underlies the stratified sampling of controls to render possible, or improve the efficiency of, an adjusted analysis designed to control confounding

  16. The Comparable Accuracy Principle • Controls be selected so that the errors of measurement of their exposures and covariates are comparable to the measurement errors of the cases.

  17. Selection of Controls • Sources of Controls • Non-hospitalized Persons • Hospitalized Patients

  18. Non-hospitalized Persons • Probability sample of the total population • School rosters • Selective service lists • Insurance company lists • Neighborhood controls • Random-digit dialing • Best friend control • Spouse or sibling

  19. Hospitalized Patients as Controls • “captive population” = more economical • Ill-defined reference population • “All other patients admitted to the hospital” Vs “a specific “other diagnosis”

  20. How Many Controls per Case? • For a fixed number of study subjects, statistical power for testing the null hypothesis is optimized by having equal numbers of cases and controls. • When the disease is extremely rare or acquisition of cases particularly expensive, however, it may be important and cost-effective to increase the numbers of controls.

  21. How Many Controls per Case? • In order to have the same statistical power (to reject the null hypothesis of no exposure effect against local alternatives) as a design with equal numbers of cases and controls, a design with M controls per case would need only (M+1)|2M as many cases. • For a fixed number of cases, the relative efficiency of a design with M controls per case relative to one that uses an unlimited number of controls is therefore only M|(M + 1).

  22. How Many Control Groups? • multiple control groups were recommended by Dorn (1959) to improve the case-control study so that it would “provide a more valid basis for generalization”. • If a whole series of control groups, e.g., of patients with different diseases, gives much the same answer and only the one affected group differs, the evidence is clearly much stronger than if the affected group differs from merely one other group.”

  23. How Many Control Groups? • Failure to detect a difference among control groups may give a false sense of security unless they were deliberately selected to differ with respect to unmeasured potential confounders. • Recent reviews of case-control methods have tended to shy away from the use of multiple control groups. They argue that there is usually a single “best” control group, and that since the discovery of an adjusted exposure difference with other control groups will force these to be discarded, the effort involved will have been wasted.

  24. Case-Control Types • Primary-based Vs Secondary-based • Population-based Vs Hospital-based

  25. Matching • Group Matching (frequency matching) • Individual Matching (matched pairs)

  26. Problems with matching • Practical Problems • Conceptual Problems

  27. Problem of Recall • Limitations in Recall • Recall Bias

  28. Case-control studies based on a defined cohort • Nested Case-Control Studies • Case-Cohort Studies

  29. advantages of conducting a case-control study in a defined cohort • No recall • Temporality is established • Efficiency • Compariblity

  30. Case-Crossover Design • Primarily used for studying the etiology of acute outcomes such as myocardial infarctions or deaths from acute events in situations where the suspected exposure is transient and its effect occurs over a short time. • The question being asked is: Was there any difference in exposure between the time period immediately preceding the outcome and a time period in the more remote past which was not immediately followed by any adverse health effect?

More Related